Regular Article
Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma

https://doi.org/10.1053/ejso.1999.1018Get rights and content

Abstract

Aim Use of molecular markers indicative of the tumour oncogenic potential and host response may enhance our prognostic information for more effective treatment of melanoma patients. The roles of HSP-70 protein, c-myc oncogene and HLA-DR antigen expression were examined in melanoma patients and related to prognostic factors, recurrence rate and long-term survival. Methods Forty patients with tumours thicker than 1 mm were included in this study. All had elective node dissection and were followed for at least 7 years. Twenty-two had microscopic nodal metastases. Both primary melanoma tumour and lymph nodes were examined for the immunohistochemical expression of HSP-70 protein, c-myc oncogene and HLA-DR antigen.Results Eighteen patients had a recurrence (45%) and 23 patients survived overall (57.50%). Positive HSP-70 expression was observed in 52.50% of the primary melanomas and was associated with improved overall survival, especially in the patient group with tumours ≥1.5 mm (70%vs 26.70%, P=0.0159). C-myc oncogene was overexpressed in 47.50% and HLA-DR antigen in 42.50% of the primary melanomas, but no correlation with survival was observed. The expression profile of these molecular markers in the primary tumour did not predict the status of regional nodes. HLA-DR expression in lymph nodes was observed exclusively in the nodal tissue surrounding the metastatic melanoma tumour in five patients. Conclusions The immunohistochemical expression profile of HSP-70 but not of c-myc oncogene or HLA-DR antigen in the primary melanoma tumour could be of certain value in the identification of patients with graver prognosis who may benefit from more aggressive therapeutic strategies.

References (42)

  • TJ Hieken et al.

    Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma

    Cancer

    (1999)
  • MM Konstadoulakis et al.

    Molecular oncogene markers and their significance in cutaneous malignant melanoma

    Ann Surg Oncol

    (1998)
  • RE Kingston et al.

    Regulation of heat shock protein 70 gene expression by c-myc

    Nature

    (1984)
  • NF Michevi et al.

    Expression of HSP-28 and three HSP-70 genes during the development and decay of thermotolerance in leucemic and nonleucemic human tumours

    Cancer Res

    (1991)
  • TM Gress et al.

    Differential expression of heat shock proteins in pancreatic carcinoma

    Cancer Res

    (1994)
  • J Anathan et al.

    Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes

    Science

    (1986)
  • DR Ciocca et al.

    Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications

    J Natl Cancer Inst

    (1993)
  • SW Carper et al.

    Heat shock proteins in thermotolerance and other cellular processes

    Cancer Res

    (1987)
  • M Harada et al.

    Heat shock proteins and the antitumor T cell response

    Biotherapy

    (1998)
  • C Botzler et al.

    Heat shock protein 72 cell-surface expression on human lung carcinoma cells is associated with increased sensitivity to lysis mediated by adherent natural killer cells

    Cancer Immunol Immunother

    (1996)
  • G Multhoff et al.

    Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells

    J Immunol

    (1997)
  • Cited by (57)

    • Regulation of heat shock protein-70 gene transcripts in breast cancer cells during hypo and hyperthermia exposure

      2019, Meta Gene
      Citation Excerpt :

      These proteins also enhance cell survival following a multitude of stresses, including elevated temperature, hypoxia, oxidative stress, altered pH, and heavy metals, etc. HSP-70 is frequently over expressed in cancer relative to normal cells, possibly due to high levels of proteotoxic stress in tumors and subsequent activation of its master regulator, heat shock factor 1 (HSF1) (Ricaniadis et al., 2001; Ramp et al., 2007; Akerfelt et al., 2010). Further, knock out studies have demonstrated its protective role against genomic instability (Hunt et al., 2004).

    • Recent advancement of piperidine moiety in treatment of cancer- A review

      2018, European Journal of Medicinal Chemistry
      Citation Excerpt :

      HSP70 is also involved in inhibition of apoptosis and is highly expressed in malignant melanoma. However, it is under-expressed in renal cancer cells [152–154]. Zeng et al. [155] targeted heat shock protein 70 (HSP70) which has an important role in regulation of apoptosis.

    • Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?

      2016, European Journal of Cancer
      Citation Excerpt :

      In these tumours, some studies found that HLA-DR expression correlated with the presence of TILs (CD4 and CD8 T cells) [37–39] and was associated with a good prognosis [40,41]. Other studies failed to demonstrate a survival advantage for HLA-DR expressing melanoma cells [42,43]. These discrepancies may be due to the fact that MHC-II expression does not always send an ‘immunogenic’ signal as suggested by the higher expression of MHC-II in metastatic lesions than in primitive lesions [37].

    • Regulation of molecular chaperones through post-translational modifications: Decrypting the chaperone code

      2013, Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
      Citation Excerpt :

      Since both cochaperones are TPR-containing proteins, it is believed that they compete for chaperone binding through the EEVD motif, thereby generating an equilibrium between folding and degradation of Hsp cargo. Expression levels of Hsp70 have been shown to be either up- or down-regulated in a variety of cancer types [18,19] and although some have questioned its validity as a prognostic marker [20] it would appear that depletion or inactivation of this chaperone sensitizes tumor cells to apoptosis [21–23]. Hsp70 can also provide a shielding effect against neurodegenerative aggregation disorders such as Huntington's and Parkinson's disease, either by directly promoting resolubilization of aggregates or by preventing apoptosis of the neurons [24,25].

    View all citing articles on Scopus

    Correspondence to: N. Ricaniadis, Skopelou 4, 17456 Alimos, Athens, Greece. Tel: +30-1-9840152; Fax: +30-1-6722259; E-mail: [email protected]

    View full text